ClinicalTrials.gov
ClinicalTrials.gov Menu

Which is a Better Breakfast? Egg or Cereal?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01413217
Recruitment Status : Completed
First Posted : August 10, 2011
Last Update Posted : February 9, 2012
Sponsor:
Collaborator:
American Egg Board
Information provided by (Responsible Party):
Nikhil Dhurandhar, Pennington Biomedical Research Center

Brief Summary:
Which is a better breakfast? Egg or cereal?

Condition or disease
Hunger Satiety

Detailed Description:
Which breakfast has the most beneficial effect on blood glucose and insulin, blood hormones and blood pressure, egg or cereal breakfast? Over a seven week period the participant will take part in eating breakfast of either egg breakfast or cereal breakfast which will be monitored. Blood samples will be taken before participants eat and different times throughout until after Lunch on day 1 and day 7. Questionnaires will be given to determine satiety (feeling of fullness) and hunger before and after breakfast and lunch. After a two week period participants will return for another week of the same procedure and tests that was followed from Day 1 though day 7 listed. However, this time participants will be eating the second of the two breakfasts whichever one they did not have for the first test period.

Study Type : Observational
Actual Enrollment : 20 participants
Observational Model: Case-Crossover
Time Perspective: Retrospective
Official Title: "Which is a Better Breakfast? Egg or Cereal?"
Study Start Date : July 2010
Actual Primary Completion Date : September 2011
Actual Study Completion Date : September 2011

Group/Cohort
Egg Breakfast
This group will be given a breakfast consisting of eggs. A breakfast consisting of eggs induces greater satiety and reduces Lunch Time intake.
Cereal Breakfast
This breakfast will consist of a breakfast that will include cereal. A breakfast cereal or white bread increases lunchtime energy intake.



Primary Outcome Measures :
  1. Caloric intake for Lunch after you have received an Egg or Cereal Breakfast and Levels of glucose, insulin, and lipids are measured. [ Time Frame: 7 weeks ]
    Before breakfast satiety following an egg breakfast compared to the other breakfast determines the impact of egg breakfast on their Lunch intake. Blood samples will be taken to test the levels of glucose, insulin, and lipids like cholesterol and triglycerides.


Secondary Outcome Measures :
  1. Satiety or hunger [ Time Frame: 7 weeks ]
    Questionnaires to determine satiety and/or hunger before and after breakfast and lunch will be given.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
In the community area of Baton Rouge, LA area exclusively random process to guarantee that each participant or population has specified chance of selection.
Criteria

Inclusion Criteria:

  • 18-60 years of age
  • not lost more than 5% of body wight in the past 3 months, or not trying to actively lose weight at the moment.
  • are not suffering from disease such as major heart conditions, cancer, type 1 diabetes, eating disorders, very high cholesterol or triglycerides levels, or any serious illness that requires intensive and long term medical treatment.

are not allergic to or sensitive to eggs, soy or wheat, and do not dislike these foods.

  • have a BMI of equal to or >30 to equal to or <60

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01413217


Locations
United States, Louisiana
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808
Sponsors and Collaborators
Pennington Biomedical Research Center
American Egg Board

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Nikhil Dhurandhar, Princiapal Investigator, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier: NCT01413217     History of Changes
Other Study ID Numbers: PBRC10010
First Posted: August 10, 2011    Key Record Dates
Last Update Posted: February 9, 2012
Last Verified: February 2012